Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Get the latest Releaf Cannabis Clinic news, updates, and announcements. Stay informed about our services, events, and medical cannabis expertise.
We know that starting a new healthcare treatment plan, especially one that has only recently been made available, can feel daunting. When patients first consider trying medical cannabis, many aren’t quite sure of what to expect or know who to turn to for answers to their questions.
As part of our Experts explain series, we sat down with Dr Sue Clenton, an expert Oncologist and Specialist Consultant at Releaf, to speak about medical cannabis treatments and chronic pain.
In the UK, General Practitioners sit on the forefront and frontline of healthcare, and they are typically a person's first port of call when something arises with their health. But, unfortunately, in the UK, GPs cannot issue a prescription for cannabis-based treatments to a patient who has never received them before. They can, however, assist in shared care agreements, hold follow-up appointments, and issue repeat prescriptions for medical cannabis.
We want to make your first steps down the road towards better health as smooth as possible. That's why we've put together this straightforward guide to help you understand what we need to know before beginning your medical cannabis treatment.
At Releaf, we’re on a mission to make accessing medical cannabis treatments as easy as possible for those that need them, and one of the ways we’re doing this is by breaking down barriers, answering FAQs, and debunking myths. So today, we’re discussing what to expect at your first medical cannabis consultation with Releaf.
In the UK, one of the most prominent misconceptions that shrouds understanding and acceptance of medical cannabis is the idea that medical cannabis is smoked. However, contrary to widespread belief, this is not the case, and in the UK, medical cannabis will never be prescribed with this intention in mind.
Releaf offers every patient a medical cannabis card with their prescription to help ensure peace of mind when administering their medicine in public. Here’s everything you need to know about how it works.
Hello, and welcome to the first of many conversations with Releaf’s specialist doctors. This week we’re speaking to our expert Rheumatologist, Dr Hanna Gul, about the benefits medical cannabis may be able to offer to patients who are struggling with fibromyalgia.
In the UK, medical cannabis has been a legal treatment option since November 2018 (just over six years). Even so, a large proportion of the population remain unaware of how prescriptions for cannabis-based treatments are issued, and how patients buy medical cannabis in the UK.
When prospective patients start to explore the world of medical cannabis, pricing strategies or how much medical cannabis costs are often at the forefront of their minds. This is completely understandable considering that to establish whether medical cannabis may be the right option for you, you need to know if it's within your budget, and therefore, the price of medical cannabis in the UK.
The Food Standards Agency and Food Standards Scotland have updated their advice on the Acceptable Daily Intake (ADI) for cannabidiol in a move that has alarmed the CBD industry. In February 2020, the FSA published advice on CBD consumption for the first time. This guidance explained that consumers should not exceed 70mg of CBD in a 24-hour period. However, this week has seen a dramatic reduction in that number, slashed to 10mg per day for healthy adults, highlighting potential long-term side effects.
The wait is over, you finally have a legal medical cannabis prescription. For some, this will have been a long wait, for others who have only just become aware of the benefits of medical cannabis, it is the start of a new journey. At Releaf we want you to feel confident about being a legal medical cannabis patient which is why we want to take a moment to talk about cannabis stigma.
This November marks the third year of celebrating Medical Cannabis Awareness Week - a whole week dedicated to highlighting the successes of the medical cannabis industry but also provides an opportunity to bring together all sectors for reflection and discussions. Drug Science, leaders of the T21 medical cannabis patient study are hosting The Patient Conference with The Medcan Family Foundation on November 3rd at Conway Hall in London. Tickets are available here.
The 1st of November 2023 is an important day for many in the medical cannabis community, because it marks five years of its legalisation in the UK. But, what you may not have known is that November the 1st is also the day dedicated to raising awareness of stress – a condition medical cannabis has shown potential in alleviating.
To get a deeper understanding of the medical cannabis industry in the UK, we’ve decided to investigate some of the key statistics that shape the cannabis landscape as we know it. The Releaf Medical Cannabis Statistic Series examined the impact of medical cannabis across three crucial domains: the economy, health, and society.
Dr Charlie Easmon is a highly acclaimed international health expert, who has ventured through over 75 countries, observing and evaluating local medical facilities for the last four decades.
Here at Releaf, we are thrilled to announce the release of our first market research report that investigates the awareness and prevalence of medical cannabis in the UK, and analyses the public perceptions and societal stigmas that surround this powerful plant.
Here at Releaf we are delighted to announce that we have joined the ranks of one of the UK's leading membership organisations for the cannabis industry: The Cannabis Industry Council (CIC).
Creator of the world famous Big Buddha Cheese, Milo Yung passed away in his sleep at age 51 on April 27th 2023 leaving behind a life of work celebrating the cannabis plant.
